中央银行和信托公司不顾公司会议分析员的预测,将Novo Nordisk的股份削减了20%以上。 Central Bank & Trust Co. cut Novo Nordisk holdings by over 20%, despite the company meeting analysts’ forecasts.

中央银行和信托公司在第一季度将其新诺迪斯克A/S股份的持有量减少了23.4%,而肯塔基独立银行的持有量增加了8.1%。 Central Bank & Trust Co. reduced its holdings in Novo Nordisk A/S shares by 23.4% in the first quarter, while Independence Bank of Kentucky increased its holdings by 8.1%. Novo Nordisk的股票以74.70美元开放,市场上限为3 352.2亿美元。 Novo Nordisk's stock opened at $74.70, with a market cap of $335.22 billion. 该公司报告本季度的EPS费用为92美元,符合分析师的预测,并商定目标价格为128.00美元。 The company reported $0.92 EPS for the quarter, meeting analysts’ forecasts and has a consensus target price of $128.00.